Stay updated on ALXN1210 vs Eculizumab in PNH Clinical Trial
Sign up to get notified when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.

Latest updates to the ALXN1210 vs Eculizumab in PNH Clinical Trial page
- Check5 days agoChange DetectedThe page displays the ClinicalTrials.gov record for the ravulizumab-versus-eculizumab PNH study, including its status, eligibility criteria, locations, treatment arms, and outcomes.SummaryDifference86%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAn NIH-wide notice about terminology changes appears above the 403 error page, and the site revision number advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe page remains a 403 Forbidden error page, with its displayed site revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check47 days agoChange DetectedNo additions or deletions were detected. The page content and state remain unchanged based on the provided changes data.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the study record content and links with site chrome visible. This indicates an access restriction rather than a content update to the study information.SummaryDifference16%

Stay in the know with updates to ALXN1210 vs Eculizumab in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.